YEAR
- 2008.04.28 Antisense activity of 2',4'-BNA targeted to PPAR gamma in THP-1 and HCT116 cells. Tachibana K, Katayama T, Ueda C, Sumitomo M, Tagami M, Ishimoto K, Yamasaki D, Tanaka T, Hamakubo T, Sakai J, Kodama T, Obika S, Imanishi T, Doi T.Nucleic Acids Symp Ser (Oxf). 2007;(51):441-2. doi: 10.1093/nass/nrm221
- 2003.04.28 Antioxidant action of 2,2,4,6-tetra-substituted 2,3-dihydro-5-hydroxybenzofuran against lipid peroxidation: effects of substituents and side chain. Yoshida Y, Noguchi N, Watanabe A, Iwaki Y, Yanagisawa M, Kodama T, Cynshi O, Niki E.Free Radic. Res. 2002 Nov;36(11):1171-8. doi: 10.1080/1071576021000016436
- 2021.12.30 Antibody mimetic drug conjugate manufactured by high-yield Escherichia coli expression and non-covalent binding system. Yamatsugu K, Katoh H, Yamashita T, Takahashi K, Aki S, Tatsumi T, Kaneko Y, Kawamura T, Miura M, Ishii M, Ohkubo K, Osawa T, Kodama T, Ishikawa S, Kanai M, Sugiyama A.Protein Expr Purif. 2022 04;192:106043. doi: 10.1016/j.pep.2021.106043
- 2019.09.05 Anti-tumor activity of dual inhibition of phosphatidylinositol 3-kinase and MDM2 against clear cell ovarian carcinoma. Makii C, Ikeda Y, Oda K, Uehara Y, Nishijima A, Koso T, Kawata Y, Kashiyama T, Miyasaka A, Sone K, Tanikawa M, Tsuruga T, Mori-Uchino M, Nagasaka K, Matsumoto Y, Wada-Hiraike O, Kawana K, Hasegawa K, Fujiwara K, Aburatani H, Osuga Y, Fujii T.Gynecol. Oncol. 2019 11;155(2):331-339. doi: 10.1016/j.ygyno.2019.08.028
- 2008.12.01 Anti-glypican 3 antibody as a potential antitumor agent for human liver cancer. Ishiguro T, Sugimoto M, Kinoshita Y, Miyazaki Y, Nakano K, Tsunoda H, Sugo I, Ohizumi I, Aburatani H, Hamakubo T, Kodama T, Tsuchiya M, Yamada-Okabe H.Cancer Res. 2008 Dec 01;68(23):9832-8. doi: 10.1158/0008-5472.CAN-08-1973
- 2008.11.18 Anti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cells. Nakano K, Orita T, Nezu J, Yoshino T, Ohizumi I, Sugimoto M, Furugaki K, Kinoshita Y, Ishiguro T, Hamakubo T, Kodama T, Aburatani H, Yamada-Okabe H, Tsuchiya M.Biochem. Biophys. Res. Commun. 2009 Jan 09;378(2):279-84. doi: 10.1016/j.bbrc.2008.11.033
- 2001.08.31 Anti-atherogenic antioxidants regulate the expression and function of proteasome alpha-type subunits in human endothelial cells. Takabe W, Kodama T, Hamakubo T, Tanaka K, Suzuki T, Aburatani H, Matsukawa N, Noguchi N.J. Biol. Chem. 2001 Nov 02;276(44):40497-501. doi: 10.1074/jbc.M104882200
- 2009.06.09 Annexin II represents metastatic potential in clear-cell renal cell carcinoma. Ohno Y, Izumi M, Kawamura T, Nishimura T, Mukai K, Tachibana M.Br. J. Cancer. 2009 Jul 21;101(2):287-94. doi: 10.1038/sj.bjc.6605128
CLOSE